Fundamental dimension Equity attribute | CLVRPeer $0.01120.00% Cap $19.65KP/E -0.0x QuantScore51/100 | BIOCQLeader $0.00030.00% Cap $788P/E -0.0x QuantScore52/100 | BRSFPeer $0.00060.00% Cap $746P/E -0.0x QuantScore23/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
94/100 |
39/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 50/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 42/100 | 44/100 | 17/100 |
Growth Revenue / earnings growth & margins | 61/100 | 20/100 | 3/100 |
Sentiment Analyst ratings, targets & revisions | 33/100 | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.0x | -0.0x |
Forward P/E (next FY) | -0.0x | -0.0x | — |
EV / EBITDA (TTM) | 0.3x | 0.0x | -0.3x |
Price / Sales | 0.0x | 0.0x | 0.0x |
Price / Free Cash Flow | -0.0x | -0.0x | -0.0x |
PEG ratio | -0.00 | 0.00 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | — | 3 / 9 |
Altman Z-Score | -10.11 (Distress) | — | -6.82 (Distress) |
Total debt / equity | 0.09 | 1.37 | 0.66 |
Quick ratio | 1.6x | 2.8x | 0.2x |
Interest coverage | -339.0x | -101.2x | -2.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +6.1% | -57.8% | -19.3% |
Net income growth YoY | +72.9% | -1036.2% | -35.6% |
Gross margin (TTM) | 37.6% | -10.0% | 25.3% |
Operating margin (FY) | -89.5% | -123.7% | -4478.1% |
FCF margin (FY) | -66.3% | -54.5% | -2781.6% |
5. Trailing price performancePrice change over period |
1M return | +11100.0% | +50.0% | -0.0% |
3M return | +11100.0% | +200.0% | -0.0% |
6M return | +1766.7% | +200.0% | +500.0% |
Year to date | +5500.0% | +200.0% | +500.0% |
1Y return | +11100.0% | +200.0% | +500.0% |
3Y return | -99.5% | -99.9% | -99.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-423.31 -3779670.7% premium | $-7,141.70 -2380567319.0% premium | $-2.76 -460899.5% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | 50% Buy50% Hold0% Sell | — | — |